COVID-19感染后胸部CT表现与肺功能的纵向评估
前瞻性研究纳入144例COVID-19出院患者,在症状出现后6、12、2年复查胸部CT和肺功能。2年时39%存在间质性肺异常(ILA),其中纤维化型23%、非纤维化型16%;ILA与呼吸道症状和弥散功能下降相关。
要点
- COVID-19后2年约39%患者存在ILA,纤维化型占23%。
- ILA患者呼吸道症状和DLCO异常更常见。
- 随访中ILA发生率随时间逐渐下降。
关键影像表现/征象
- 2年随访CT上39%(56/144)存在ILA,其中纤维化型ILA占23%(33/144),非纤维化型ILA占16%(23/144)。
- 61%(88/144)患者达到完全影像学吸收。
- ILA发生率在6个月、12个月和2年分别为54%、42%和39%(P < .001)。
诊断标准与关键数值
- 采用间质性肺异常(ILA)及其亚类纤维化型ILA和非纤维化型ILA描述随访CT残留异常。
- ILA患者呼吸道症状发生率34% vs 完全吸收者15%(P = .007)。
- ILA患者DLCO异常率43% vs 完全吸收者20%(P = .004)。
临床应用与阅片要点
- COVID-19康复者随访CT应关注ILA征象并区分纤维化型与非纤维化型。
- 发现ILA时建议结合肺功能(尤其DLCO)和呼吸道症状综合评估。
局限性
- 单中心前瞻性研究,样本量144例。
- 仅纳入出院患者且排除入院无CT或出院时完全吸收者,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Information on pulmonary sequelae and pulmonary function 2 years after recovery from SARS-CoV-2 infection is lacking. Purpose To longitudinally assess changes in chest CT abnormalities and pulmonary function in individuals after SARS-CoV-2 infection. Materials and Methods In this prospective study, participants discharged from the hospital after SARS-CoV-2 infection from January 20 to March 10, 2020, were considered for enrollment. Participants without chest CT scans at admission or with complete resolution of lung abnormalities at discharge were excluded. Serial chest CT scans and pulmonary function test results were obtained 6 months (June 20 to August 31, 2020), 12 months (December 20, 2020, to February 3, 2021), and 2 years (November 16, 2021, to January 10, 2022) after symptom onset. The term interstitial lung abnormality (ILA) and two subcategories, fibrotic ILAs and nonfibrotic ILAs, were used to describe residual CT abnormalities on follow-up CT scans. Differences between groups were compared with the χ2 test, Fisher exact test, or independent samples t test. Results Overall, 144 participants (median age, 60 years [range, 27-80 years]; 79 men) were included. On 2-year follow-up CT scans, 39% of participants (56 of 144) had ILAs, including 23% (33 of 144) with fibrotic ILAs and 16% (23 of 144) with nonfibrotic ILAs. The remaining 88 of 144 participants (61%) showed complete radiologic resolution. Over 2 years, the incidence of ILAs gradually decreased (54%, 42%, and 39% of participants at 6 months, 12 months, and 2 years, respectively; P < .001). Respiratory symptoms (34% vs 15%, P = .007) and abnormal diffusing capacity of lung for carbon monoxide (43% vs 20%, P = .004) occurred more frequently in participants with ILAs than in those with complete radiologic resolution. Conclusion More than one-third of participants had persistent interstitial lung abnormalities 2 years after COVID-19 infection, which were associated with respiratory symptoms and decreased diffusion pulmonary function. Chinese Clinical Trial Registry no. ChiCTR2000038609 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by van Beek in this issue.
引用
- Han, Chen, Fan, et al. Longitudinal Assessment of Chest CT Findings and Pulmonary Function after COVID-19 Infection. Radiology. 2023. PMID: 36786698. doi:10.1148/radiol.222888
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。